Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

MAB2500 Anti-Collagen Type VII Antibody, clone 32,-VII

MAB2500
100 µg  
Purchase on Sigma-Aldrich

特卖

概述

Replacement Information

重要规格表

Species ReactivityKey ApplicationsHostFormatAntibody Type
B, HELISAMPurifiedMonoclonal Antibody
Description
Catalogue NumberMAB2500
Brand Family Chemicon®
Trade Name
  • Chemicon
DescriptionAnti-Collagen Type VII Antibody, clone 32,-VII
References
Product Information
FormatPurified
PresentationLiquid at 1 mg/mL in 20 mM phosphate buffer, 250 mM NaCl, pH 7.6, containing 0.1% sodium azide.
Quality LevelMQ100
Applications
ApplicationAnti-Collagen Type VII Antibody, clone 32, -VII detects level of Collagen Type VII & has been published & validated for use in ELISA.
Key Applications
  • ELISA
Application NotesELISA

IH on unfixed, weakly fixed tissue sections.
Biological Information
Clone32, mAb-VII
HostMouse
SpecificityMonoclonal antibody MAB2500 recognizes human and bovine Type VII Collagen.
IsotypeIgG1
Species Reactivity
  • Bovine
  • Human
Antibody TypeMonoclonal Antibody
Entrez Gene Number
Entrez Gene SummaryThis gene encodes the alpha chain of type VII collagen. The type VII collagen fibril, composed of three identical alpha collagen chains, is restricted to the basement zone beneath stratified squamous epithelia. It functions as an anchoring fibril between the external epithelia and the underlying stroma. Mutations in this gene are associated with all forms of dystrophic epidermolysis bullosa. In the absence of mutations, however, an acquired form of this disease can result from an autoimmune response made to type VII collagen.
Gene Symbol
  • COL7A1
  • EBR1
  • EBD1
  • EBDCT
UniProt Number
UniProt SummaryFUNCTION: SwissProt: Q02388 # Stratified squamous epithelial basement membrane protein that forms anchoring fibrils which may contribute to epithelial basement membrane organization and adherence by interacting with extracellular matrix (ECM) proteins such as type IV collagen.
SIZE: 2944 amino acids; 295220 Da
SUBUNIT: Homotrimer.
SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix, basement membrane.
PTM: Prolines at the third position of the tripeptide repeating unit (G-X-Y) are hydroxylated in some or all of the chains.
DISEASE: SwissProt: Q02388 # Epidermolysis bullosa acquisita (EBA) is an autoimmune acquired blistering skin disease resulting from autoantibodies to type VII collagen. & Defects in COL7A1 are the cause of dystrophic epidermolysis bullosa (DEB) [MIM:131750, 226600]. DEB is a group of blistering skin diseases with either autosomal dominant or autosomal recessive inheritance. Ultrastructurally, DEB is characterized by tissue separation which occurs below the dermal- epidermal basement membrane at the level of the anchoring fibrils. Various clinical types with different severity are recognized. DEB Pasini type is a severe, dominantly inherited form. Among the recessively inherited forms, the Hallopeau-Siemens type epidermolysis bullosa is the most severe form. It manifests with mutilating scarring, joint contractures, corneal erosions, esophagus structures, and propensity to formation of cutaneous squamous cell carcinomas leading to premature demise of the affected individuals. Two milder recessive forms are dystrophic epidermolysis bullosa mitis type and the localized type. The mitis type shows lifelong blistering tendency, with limited scarring and less frequent extracutaneous manifestations. In the localized type, blistering and scarring are predominantly localized to the extremities. & Defects in COL7A1 are the cause of transient bullous dermolysis of the newborn (TBDN) [MIM:131705]. TBDN is a neonatal skin blistering disorder with features similar to those observed in dystrophic epidermolysis bullosa. TBDN is characterized by sub- epidermal blisters, reduced or abnormal anchoring fibrils at the dermo-epidermal junction, and electron-dense inclusions in keratinocytes. TBDN heals spontaneously or strongly improves within the first months and years of life. & Defects in COL7A1 are the cause of pretibial type dystrophic epidermolysis bullosa (P-DEB) [MIM:131850]. Inheritance is autosomal dominant. & Defects in COL7A1 are the cause of Bart type dystrophic epidermolysis bullosa (B-DEB) [MIM:132000]; also known as epidermolysis bullosa with congenital localized absence of skin and deformity of nails. Inheritance is autosomal dominant. & Defects in COL7A1 are the cause of epidermolysis bullosa pruriginosa (EBP) [MIM:604129]. EBP is a distinct clinical subtype of DEB. It is characterized by skin fragility, blistering, scar formation, intense pruritus and excoriated prurigo nodules. Onset is in early childhood, but in some cases is delayed until the second or third decade of life. Inheritance can be autosomal dominant or recessive. & Defects in COL7A1 are the cause of isolated toenail dystrophy without skin fragility [MIM:607523]. & Defects in COL7A1 are the cause of epidermolysis bullosa dystrophica with subcorneal cleavage (EBDSC) [MIM:607600]; also known as epidermolysis bullosa simplex superficialis (EBSS). EBDSC is a new variant of epidermolysis bullosa simplex (EBS), characterized by the development of skin cleavage just beneath the level of stratum corneum. It appears to be transmitted as an autosomal dominant trait and differs from other autosomal dominant forms of EBS by the common findings of milia and atrophic scarring, as well as involvement of oral and/or ocular surfaces. It is further differentiated by the presence of blisters and the absence of spontaneous continual exfoliation or peeling.
SIMILARITY: SwissProt: Q02388 ## Contains 1 BPTI/Kunitz inhibitor domain. & Contains 9 fibronectin type-III domains. & Contains 2 VWFA domains.
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsMaintain refrigerated at 2-8°C in undiluted aliquots for up to 12 months.
Packaging Information
Material Size100 µg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
产品目录编号 GTIN
MAB2500 04053252577246

Documentation

Anti-Collagen Type VII Antibody, clone 32,-VII MSDS

职位

物料安全数据表 (MSDS) 

Anti-Collagen Type VII Antibody, clone 32,-VII 分析证书

标题批号
MOUSE ANTI COLLAGEN VII MONOCLONAL ANTIBODY - 2038277 2038277
MOUSE ANTI COLLAGEN VII MONOCLONAL ANTIBODY - 2127810 2127810
MOUSE ANTI COLLAGEN VII MONOCLONAL ANTIBODY - 2140047 2140047
MOUSE ANTI COLLAGEN VII MONOCLONAL ANTIBODY - 2383547 2383547
MOUSE ANTI COLLAGEN VII - 2561984 2561984
MOUSE ANTI COLLAGEN VII - 3194690 3194690
MOUSE ANTI COLLAGEN VII - 3218275 3218275
MOUSE ANTI COLLAGEN VII - 3222656 3222656
MOUSE ANTI COLLAGEN VII - 3234580 3234580
MOUSE ANTI COLLAGEN VII - 3283663 3283663

参考

参考概述应用公共医疗ID
Control of somatic tissue differentiation by the long non-coding RNA TINCR.
Kretz, M; Siprashvili, Z; Chu, C; Webster, DE; Zehnder, A; Qu, K; Lee, CS; Flockhart, RJ; Groff, AF; Chow, J; Johnston, D; Kim, GE; Spitale, RC; Flynn, RA; Zheng, GX; Aiyer, S; Raj, A; Rinn, JL; Chang, HY; Khavari, PA
Nature  493  231-5  2013

显示摘要
23201690 23201690
Laminin-511 and integrin beta-1 in hair follicle development and basal cell carcinoma formation.
DeRouen, MC; Zhen, H; Tan, SH; Williams, S; Marinkovich, MP; Oro, AE
BMC developmental biology  10  112  2010

显示摘要 全文本文章
21067603 21067603
The development and characterization of an in vitro model of psoriasis.
Barker, CL; McHale, MT; Gillies, AK; Waller, J; Pearce, DM; Osborne, J; Hutchinson, PE; Smith, GM; Pringle, JH
The Journal of investigative dermatology  123  892-901  2004

显示摘要
Immunohistochemistry15482477 15482477